Provera Lawsuit | 2024 Latest Updates

The widely-prescribed birth control shot Provera (generic: depot medroxyprogesterone acetate, or “DMPA”) has recently been linked to an increased risk for a life-threatening type of brain tumor called meningioma. Numerous patients are suing the drugmaker Pfizer for failing to warn of the brain tumor risk with Provera.
Award Logos
C.L. Mike Schmidt Published by C.L. Mike Schmidt
Free Confidential Provera Lawsuit Review
If you or a loved one was diagnosed with a brain tumor (meningioma) after receiving a Provera injection, you should contact our law firm immediately. Provera victims may be entitled to compensation by filing a Provera Class Action Lawsuit and we can help.

Please click the button below for a Free Confidential Case Evaluation or call us toll-free 24 hrs/day by dialing (866) 588-0600 to discuss your legal options. Our Provera attorneys are filing Provera lawsuits and investigating potential Provera cases now.

Start My Free Provera Brain Tumor Lawsuit Review

If you or a loved one experienced brain tumors (meningioma) following Provera treatment, you may be entitled to pursue compensation. At Schmidt & Clark, we are dedicated to helping individuals who have suffered due to these dangerous complications. Our experienced legal team is here to guide you through the process and fight for the compensation you deserve. Contact Schmidt & Clark today for a free, no-obligation consultation.

Provera Lawsuit Overview

Provera lawsuits are being filed against Pfizer for brain tumors (meningiomas) allegedly caused by the synthetic progestin hormone medication. Recent studies have linked prolonged use of medroxyprogesterone acetate, the active ingredient in Provera, to a 5.6 times higher risk of developing intracranial meningiomas when used for more than one year. Despite new evidence linking Depo-Provera to meningioma brain tumors, Pfizer has updated prescribing guidelines but has yet to modify the warning label.

Latest Provera Lawsuit Updates

  • September 17, 2024 – Depo-Provera meningioma brain tumor lawsuits are gaining significant national attention from mass tort attorneys. Data from the FDA suggest that a large number of women received Depo-Provera birth control shots, indicating a potentially substantial pool of plaintiffs.
  • July 14, 2024 – A report in the New York Post highlights the case of a nurse who developed a brain tumor, causing her to experience symptoms such as hearing people speak different languages. She attributes her meningioma to hormone replacement therapy (HRT), Depo-Provera injections, and IVF treatments, all of which contain progesterone.
  • July 12, 2024 – Following new evidence linking Depo-Provera to meningioma brain tumors, Pfizer updated the prescribing guidelines and information for the drug. However, despite these changes, Pfizer has yet to modify the warning label for Depo-Provera.
  • April 25, 2024 – Pfizer, the manufacturer of Depo-Provera, issued a public statement addressing the BMJ study that linked prolonged Depo-Provera use to meningioma brain tumors. Pfizer acknowledged the potential risks and announced that they are working with regulatory agencies to update product labels and patient information with appropriate warnings.
  • March 29, 2024 – A groundbreaking study published in the British Medical Journal revealed that long-term use of Depo-Provera significantly increases the risk of developing meningioma brain tumors. The study found that women who used Depo-Provera were more than five times as likely to be diagnosed with meningiomas compared to women who had never used the birth control shot.

Provera Reports and Statistics

  • According to the BMJ study, prolonged use of medroxyprogesterone acetate (the active ingredient in Provera) for more than one year increases the risk of developing intracranial meningiomas by 5.6 times [1].
  • The study analyzed data from over 18,000 women who underwent surgery for intracranial meningiomas between 2009 and 2018.
  • Each case was compared to five women without a history of meningiomas to establish control groups.
  • Research indicates that approximately 74 million users worldwide use medroxyprogesterone acetate for birth control, suggesting a potentially high number of attributable meningiomas.
  • The study found that other menopause drugs, including medrogestone and promegestone, also increased the risk of meningioma by 4.1-fold and 2.7-fold, respectively.
  • Importantly, no increased risk of meningioma was found with the use of levonorgestrel, a progestogen used in IUDs and emergency contraceptives like Plan B.

Provera Injuries & Side Effects

Meningiomas can cause serious disability if they affect adjacent brain tissue, nerves, or vessels.

  • Neurological Symptoms: Headaches, dizziness, seizures, hyperreflexia
  • Sensory Issues: Vision changes (double vision, blurriness, loss of vision), hearing loss
  • Cognitive Problems: Memory problems, behavioral or personality changes
  • Physical Symptoms: Nausea, vomiting, muscle weakness or paralysis in certain areas of the body

Do You Qualify for a Provera Lawsuit?

You may qualify for a Provera lawsuit if:

  • You received Provera treatment
  • You were diagnosed with a brain tumor (intracranial meningioma)
  • Your meningioma required medical treatment or hospitalization
  • You can provide medical documentation linking your injuries to Provera

Evidence Required for a Provera Lawsuit

  • Medical records documenting your Provera treatment
  • Diagnosis of meningioma brain tumor
  • Medical documentation linking the tumor to Provera use

Damages You Can Recover

While specific damage details aren’t mentioned in the original text, typical recoverable damages in pharmaceutical lawsuits include:

  • Medical expenses for treatment of meningioma
  • Lost wages due to inability to work
  • Pain and suffering caused by the brain tumor
  • Other related damages

Statute of Limitations for Provera Lawsuits

It’s important to note that all personal injury and product liability lawsuits, including those involving Provera, are subject to statutes of limitations. These legal deadlines vary by state and typically range from 1-6 years from when the injury was discovered or should have been discovered. Because of these time constraints, anyone who believes they may have been harmed by Provera should consult with an attorney as soon as possible to preserve their legal rights.

Frequently Asked Questions

What is Provera and what is it used for?

Provera is a prescription medication containing medroxyprogesterone acetate, a synthetic progestin hormone designed to mimic the effects of natural progesterone. It’s used to treat menstrual disorders, endometriosis, PCOS, provide menopause support, prevent uterine cancer in certain patients, and reduce hot flashes in men undergoing prostate cancer treatment.

What is the link between Provera and brain tumors?

A recent study published in the BMJ found that prolonged use of medroxyprogesterone acetate, the active ingredient in Provera, raises the risk of developing intracranial meningiomas by 5.6 times if used for more than one year.

What are meningiomas?

Meningiomas are tumors that form in the meninges, the three protective layers of tissue surrounding the brain and spinal cord. Although most meningiomas are benign (noncancerous), they can sometimes become malignant (cancerous) and cause serious health issues if left untreated [2].

What are the symptoms of meningioma brain tumors?

Symptoms of meningiomas include headaches, dizziness, nausea, vomiting, vision changes, hearing loss, seizures, behavioral changes, memory problems, hyperreflexia, and muscle weakness or paralysis in certain areas of the body.

How is Pfizer responding to the meningioma risk?

On April 25, 2024, Pfizer acknowledged the potential risks identified in the BMJ study and announced they are working with regulatory agencies to update product labels and patient information with appropriate warnings. As of July 12, 2024, Pfizer has updated prescribing guidelines but has not yet modified the warning label for Depo-Provera.

When did reports of Provera-related brain tumors begin to emerge?

According to the timeline provided, significant attention to Provera-related brain tumors began around March 29, 2024, when the BMJ study was published linking long-term Depo-Provera use to meningioma brain tumors.

How can I start a Provera brain tumor lawsuit?

If you or a loved one was diagnosed with a brain tumor (meningioma) after receiving a Provera injection, you should contact Schmidt & Clark law firm for a free case review. You can call toll-free 24 hours/day at (866) 588-0600 or request a free confidential case evaluation through their website.

Related Articles:

See all related dangerous drug lawsuits our attorneys covered so far.

Time is limited to pursue legal action in Provera brain tumor cases. Don’t delay seeking legal help as statutes of limitations may apply to your case.

The Dangerous Drugs Litigation Group at Schmidt & Clark, LLP law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Provera Brain Tumor Lawsuits. We are handling individual litigation nationwide and are currently accepting new brain tumor cases in all 50 states.

Our services include:

  • Free, confidential consultations
  • No upfront costs or fees
  • Payment only if we win your case

Choose our lawyers

Have you or a loved one suffered from the adverse side effects caused by defective medication?

References

  1. https://www.bmj.com/content/384/bmj-2023-078078
  2. https://my.clevelandclinic.org/health/diseases/17858-meningioma

 

Get a Free Case Review

You may be entitled to financial compensation.
Secure Submission